Brief: Pila Pharma Q1 Rev Up At SEK 535 Mln
26/04/2022 07:15
April 26 (Reuters) - Pila Pharma AB PILA.ST :
* PUBLISHES INTERIM REPORT JANUARY 1 - MARCH 31, 2022
* Q1 REVENUE WAS SEK 535 KSEK (0)
* Q1 OPERATING LOSS (EBIT) WAS - 2 403 KSEK (- 2 462)
Source text for Eikon: ID:nBQN9L9fs2
Further company coverage: PILA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))